Linus Pauling established the conceptual framework for understanding and mimicking enzymes more than six decades ago 1 . The notion that enzymes selectively stabilize the rate-limiting transition state of the catalysed reaction relative to the bound ground state reduces the problem of design to one of molecular recognition. Nevertheless, past attempts to capitalize on this idea, for example by using transition state analogues to elicit antibodies with catalytic activities 2 , have generally failed to deliver true enzymatic rates. The advent of computational design approaches, combined with directed evolution, has provided an opportunity to revisit this problem. Starting from a computationally designed catalyst for the Kemp elimination 3 -a well-studied model system for proton transfer from carbon-we show that an artificial enzyme can be evolved that accelerates an elementary chemical reaction 6 3 10 8 -fold, approaching the exceptional efficiency of highly optimized natural enzymes such as triosephosphate isomerase. A 1.09 Å resolution crystal structure of the evolved enzyme indicates that familiar catalytic strategies such as shape complementarity and precisely placed catalytic groups can be successfully harnessed to afford such high rate accelerations, making us optimistic about the prospects of designing more sophisticated catalysts.
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Proton transfer from carbon enables an impressive array of racemizations, carboxylations, eliminations, isomerizations and carbon-carbon bond-forming reactions. Although such reactions often have considerable kinetic and thermodynamic barriers, the enzymes that have evolved to catalyse them are among the most efficient known. For example, triosephosphate isomerase (TIM) accelerates the conversion of dihydroxyacetone phosphate to R-glyceraldehyde-3-phosphate, a key step in glycolysis, more than a billion-fold relative to the spontaneous reaction at neutral pH 4 . Because its efficiency is limited by diffusive steps rather than chemistry 5 , TIM is considered a 'perfect' enzyme. Detailed biochemical and structural studies, coupled with mutagenesis and mechanistic data, have provided good qualitative understanding of TIM catalysis 6, 7 . The substrate binds in a shape complementary pocket, sequestered from bulk solvent by the closing of a mobile protein loop, where it is deprotonated by the carboxylate side chain of Glu 165. The side chains of His 95 and Lys 12 facilitate this process by electrostatically stabilizing the resulting enolate intermediate and flanking transition states. Reprotonation of the intermediate by Glu 165 yields R-glyceraldehyde-3-phosphate, which is released from the enzyme in a slow step to complete the catalytic cycle. Accessory interactions at the active site accurately place the catalytic residues and fine-tune their reactivity. Binding interactions with the non-reacting phosphodianion of the substrate further contribute to catalytic efficiency by positioning the substrate within the active site and activating the catalytic residues 8 . In attempts to recapitulate such features in artificial catalysts, the basepromoted deprotonation of 5-nitrobenzisoxazole (1, Fig. 1 )-the so-called Kemp elimination 9 -has been extensively studied. This abiological reaction is roughly 30 times faster than deprotonation of dihydroxyacetone phosphate 9, 10 , but experimentally more tractable because it occurs by a one-step mechanism in which proton transfer is coupled to irreversible cleavage of the N-O bond. Although many catalysts for the Kemp elimination have been described, including catalytic antibodies 11 and computationally designed enzymes 12, 13 , they typically effect proton abstraction with relatively modest turnover numbers (k cat , 1 s
21
). Even after extensive directed evolution, the most active artificial enzyme generated so far, KE59. 13 . Optimization of HG3 was based on an evolutionary strategy that included both global and local mutagenesis ( Supplementary Fig. 1 ). Error-prone PCR and DNA shuffling were used to target the entire gene and identify 'hot spots' (rounds 1-14; 16-17); small focused libraries were subsequently constructed to interrogate these and other positions in the active site and substrate entry tunnel (rounds 1b; 15). On average, only one amino acid mutation per evolutionary round was fixed (Fig. 2a, b and Supplementary Fig. 2 ), improving the likelihood of only accumulating beneficial changes along the evolutionary trajectory. In contrast to many laboratory optimization experiments, catalytic improvements during the evolution of HG3 were accompanied by increased thermostability (change 15 . HG3.17 uses the carboxylate side chain of Asp 127 for proton abstraction (pK a 5 6.0, Supplementary Fig. 3b) ; replacement of this residue with alanine or asparagine leads to a .10 5 -fold reduction in activity ( Supplementary Fig. 3c ). The active site carboxylate is 4 3 10 9 -fold more effective than a simple carboxylate base such as acetate in aqueous solution (Supplementary Table 1) . Notably, catalytic improvement over the original computational design was achieved entirely by increasing the turnover number, not substrate affinity. As a consequence, HG3.17 promotes proton transfer from 5-nitrobenzisoxazole with a 6 3 10 8 -fold rate acceleration over the uncatalysed reaction (k cat /k uncat ), outperforming other Kemp eliminases by nearly two orders of magnitude 11, 14 (Fig. 2c) . Given the importance of high turnover numbers for industrial biocatalysis, where rapid conversion of substrate to product is desired, such high reactivity is noteworthy. Product inhibition, a common problem in enzyme catalysis, is also negligible in the case of HG3.17, which readily achieves .3 3 10 5 turnovers per active site (Fig. 2d ).
These results demonstrate that a bottom-up approach combining de novo computational design with laboratory evolution can yield artificial biocatalysts capable of accelerating proton transfer with true enzymatic efficiency. To determine the origins of its catalytic prowess, the HG3.17 enzyme was co-crystallized with 6-nitrobenzotriazole (3). This stable transition state analogue, which inhibits the enzyme with an inhibition constant (K i ) of 2 mM (Supplementary Fig. 3d ), has an acidic N-H bond (pK a 5 6.3) that mimics the scissile C-H bond of the substrate. The X-ray structure of the complex, solved at 1.09 Å resolution, shows the ligand deeply buried in the active site (Fig. 3a) , shielded from bulk solvent and oriented in a catalytically productive pose (Fig. 3b) . Comparison of HG3.17 with the starting HG3 enzyme 3 suggests that three factors were decisive in the evolution of high activity.
First, the evolved active site exhibits extraordinarily high shape complementarity to the ligand. After binding, approximately 95% of the ligand surface is buried (Fig. 3a) . A tight fit is achieved by a combination of side chain and backbone interactions plus a single ordered water molecule. Recognition of small apolar ligands such as 5-nitrobenzisoxazole and 6-nitrobenzotriazole constitutes a challenge for computational design, and ambiguous ligand binding modes are not uncommon 14 . This was the case with the computationally designed HG3 enzyme, which binds 6-nitrobenzotriazole in two different orientations 3 . By contrast, HG3.17 displays only a single binding mode in which the ligand is flipped relative to the original design model 3 . Excluding nonproductive binding modes in this way (Fig. 4a) represents a relatively simple means of increasing catalytic efficiency. In addition to aiding catalysis by maximizing attractive interactions with the transition state 16 , snug binding can enhance substrate specificity 17 . In contrast to many Kemp eliminases that accept a wide range of substituted benzisoxazoles 14, 18 , HG3.17 is rather discriminating. Benzisoxazoles lacking a substituent at the 5 position or containing groups at the 6 or 7 positions are much poorer substrates than intrinsic reactivity would predict ( Supplementary Fig. 3e ).
Second, ligand alignment with Asp 127, the catalytic base, was optimized by evolution. Asp 127 sits at the bottom of a hydrophobic binding pocket (Fig. 3a) . One carboxylate oxygen is hydrogen bonded to a buried water molecule, whereas the other forms a tight hydrogen bond with the acidic proton of the bound benzotriazole (Fig. 3b) . The hydrogen bond to the ligand is unusually short (2.53 Å )-significantly shorter than in other Kemp eliminases 14, 19 -and its geometry converged towards optimal values for hydrogen bonding interactions over the evolutionary trajectory ( Fig. 4b and Supplementary Fig. 4) . Notably, although the syn orbital of a carboxylate has been argued to be more basic than the anti orbital 20 , this interaction involves the anti orbital of the Asp 127 carboxylate (Fig. 3b) . The efficiency of HG3.17 suggests that the energy penalty of using the 'wrong' lone pair for proton abstraction may be small if the base and substrate are precisely aligned. A nonspecific medium effect does not seem to be the source of the observed boost in catalytic efficiency. Although the apolar environment of the active site undoubtedly contributes to the high reactivity of the desolvated carboxylate ion 18 , the starting design and the evolved catalyst have similar pH profiles ( Supplementary Fig. 3b ), arguing against a substantial change in either Asp 127 basicity or the desolvation penalty associated with substrate binding.
Third and perhaps most importantly, a new catalytic group capable of stabilizing developing negative charge in the transition state emerged over the course of evolution (Fig. 4c) . This innovation, which is reminiscent of the oxyanion hole in serine proteases 21 , sets HG3.17 apart from other Kemp eliminases 11, 14 . Although Thr 265 was originally supposed 
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to donate a hydrogen bond to the phenoxide leaving group 3 , the flipped orientation of the substrate in the evolved variant precludes such an interaction. Instead, the side chain of Gln 50 assumes this role, making a direct hydrogen bonding contact (3.10 Å ) with N3 of 6-nitrobenzotriazole (Fig. 3b ). This residue, which was mutated twice during evolution, first from lysine to histidine and later from histidine to glutamine (Supplementary Fig. 2 ), is well placed to position the substrate for proton abstraction and simultaneously facilitate charge transfer from the buried carboxylate to the phenolic oxygen. Consistent with this hypothesis, replacement of Gln 50 by alanine reduces the k cat /K m by 50-fold ( Supplementary Fig. 3c ). Two supporting hydrogenbonding interactions with backbone amides anchor the side-chain amide in a catalytically productive orientation. Complementing the significant entropic advantage expected for effectively positioning this functional group, the low dielectric environment of the binding pocket would be expected to enhance its interaction with the charged transition state 22 .
Creation of highly preorganized environments sensitive to the small changes in structure and charge distribution that distinguish ground and transition state is extraordinarily challenging 23 . As a consequence, reducing the activation energy of an elementary chemical step is considered to be the most demanding aspect of enzyme evolution 24 . That effective transition-state tuning could be achieved for the Kemp elimination through a combination of computational design and experimental evolution is thus good news for enzyme engineers. One may nevertheless wonder why computation alone was not more successful, particularly as the evolved HG3.17 resembles the idealized active site targeted by design 3 . The answer probably lies in the tradeoffs between speed and accuracy that current design algorithms make to facilitate searches of sequence space 25 . The discrete amino acid side-chain rotamers and ligand placement schemes do not allow the side-chain functional groups (or bound ligand) to adopt conformations with the sub-Å ngstrom precision necessary for high catalytic efficiency. Inaccurate treatment of long-range electrostatic interactions, of paramount importance in enzymatic catalysis 26 , and the simplifying assumption that the protein scaffold is rigid compound this problem.
More advanced computational techniques will be needed to tackle these challenges. In this regard, 'multistate' design may have a role in lessening the severity of the fixed backbone assumption by allowing the sequence design calculation to sample from a large ensemble of closely related structural states 27 . Using an ensemble of states could capture the backbone structural variations needed to allow for a more precise positioning of relevant catalytic side chains. In addition, classical molecular dynamics and combined quantum mechanics/molecular mechanics simulations have shown some promise in evaluating and ranking designs 28 , and will probably become increasingly important for identifying improved lead candidates for experimental optimization.
Although HG3.17 catalyses the deprotonation of 5-nitrobenzisoxazole with remarkable efficiency, its apparent second-order rate constant k cat /K m is still three to four orders of magnitude below the diffusion limit (10 8 -10 9 M 21 s
21
). Future efforts to turn HG3.17 into a 'perfect' enzyme 6 might profitably focus on optimizing the dynamic properties of the protein. Because 6-nitrobenzotriazole is almost completely buried within the binding pocket (Fig. 3a) , ligand association and dissociation necessarily require considerable protein conformational changes. Although many beneficial mutations accumulated near the mouth of the binding pocket (Fig. 2b) , shortening and widening the substrate entry tunnel relative to the starting design ( Supplementary Fig. 3f ), structural rearrangements may still hinder enzyme-substrate encounter 17 . Design and evolution of a highly active Kemp eliminase demonstrates the feasibility of mimicking the precisely tailored active sites of true enzymes. Although the catalytic devices that emerged during HG3 optimization (Fig. 4) 
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beyond the current capabilities of computational methods. In the future, generalizing de novo enzyme design to other chemical reactions will undoubtedly profit from improved algorithms and increased computing power 29, 30 . In the quest for enzyme-like activities, however, it is likely that designed active sites will continue to require adjustment and refinement through evolution, nature's own optimization strategy.
METHODS SUMMARY
In vitro evolution. Gene libraries of HG3 were generated by error-prone PCR using the GeneMorph II Random Mutagenesis kit (Stratagene) and by DNA shuffling of the most active variants from each round. Focused libraries were generated by conventional site-directed mutagenesis using oligonucleotides containing degenerate codons. Kemp eliminase activity of 800-1,000 variants per round was assayed with 5-nitrobenzisoxazole in 96-well plates as previously described 14 . The clones with the largest increase in activity, typically corresponding to about 1% of the screened population, were picked from replica plates for plasmid isolation, sequencing and further diversification. Biochemical characterization. All HG3 variants were produced as carboxy-terminally His-tagged proteins in Escherichia coli BL21-Gold(DE3), and purified by affinity (Ni-NTA) and cation exchange chromatography. Individual point mutants were generated by conventional site-directed mutagenesis. Cleavage of 5-nitrobenzisoxazole was assayed at 27 uC in 50 mM phosphate buffer, 100 mM NaCl containing 10% methanol, pH 7.0. Product formation was monitored spectroscopically at 380 nm (De 5 15,800 M 21 cm
21
). Steady-state parameters were obtained by fitting the data to the Michaelis-Menten equation. Crystallization and structure determination. A variant of HG3.17 containing reversions of two surface mutations (Asn47Glu/Asp300Asn) and complexed with transition state analogue 6-nitrobenzotriazole (3) was crystallized by vapour diffusion in sitting drops. Diffraction data were collected at 100 K at the Swiss Light Source (SLS) X06SA PX beamline. The structure was solved by molecular replacement with PHASER and refined using the programs PHENIX and COOT. Refinement statistics are summarized in Supplementary Table 2 .
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Starting point for in vitro evolution. Kemp eliminase HG3 (ref.
3) was designed into the thermostable xylanase TAX from Thermoascus aurantiacus (PDB accession code 1GOR). Eleven mutations were introduced into the inert scaffold (Gln42Met, Thr44Trp, Arg81Gly, His83Gly, Thr84Met, Asn130Gly, Asn172Met, Ala234Ser, Thr236Leu, Glu237Met and Trp267Phe) using the method described previously 31 . The resulting enzyme served as the starting point for several rounds of directed evolution via whole gene random mutagenesis, DNA shuffling, and the use of focused libraries. Library construction. The gene encoding HG3 was subcloned into the commercial pET-11b(1) vector (Novagen). Primers for library cloning and the focused libraries (Supplementary Table 3) were purchased from Microsynth AG (Balgach). Diversity in gene libraries was created using error-prone PCR 32 , DNA shuffling 33 and combinatorial site-directed mutagenesis 34, 35 . Randomization experiments targeting the entire gene were carried out by error-prone PCR using the GeneMorph II Random Mutagenesis kit from Stratagene. Site-specific saturation mutagenesis targeting defined sites was achieved with primer sets that overlapped on the 59 side of the randomized position, together with appropriate flanking primers (T7 terminator and T7 alternative). Randomized codons were incorporated into the sense primer. Furthermore, a mismatch at the wobble position of the preceding codon was introduced to ensure unbiased incorporation of all possible base combinations. The length of the sense primers was determined by the desired melting temperature of the sequence (T M 5 53 6 2 uC) on the 39 and 59 sides of the mutation. Melting temperatures were calculated using the nearest neighbour method 36 . The genes for all focused libraries and point mutants were generated by an overlap extension PCR procedure. First, gene fragments containing the desired mutations were produced by standard PCR using the primer combination described above and subsequently purified by agarose gel electrophoresis. Next, the gene fragments were assembled by combining 100 ng of each fragment for three PCR cycles, followed by addition of the flanking primers for amplification of the entire construct. The PCR products (inserts) were subsequently purified by agarose gel electrophoresis. Integration of the gene libraries into the library vectors pET-11b(1) was achieved by standard cloning techniques. In all cases, double restriction digests of the vectors and inserts were carried out using appropriate restriction endonucleases according to the manufacturer's instructions. The NdeI restriction endonuclease was used in fivefold excess and extended incubation times of at least 6 h to compensate for its weak activity. The vector and insert fragments were purified by agarose gel electrophoresis. The libraries were ligated at 16 uC for 16-72 h with a 1:3 vector-toinsert ratio (final vector concentration 10 nM) and 30 U ml 21 T4 DNA ligase. Finally, the ligation mixtures were purified by phenol-chloroform extraction, desalted and concentrated in a Microcon YM-30 device (Millipore) before transformation of BL21-Gold(DE3) cells. The transformation mixture was plated on LB agar containing 150 mg l 21 ampicillin. Library quality and mutation rate were assessed by sequence analysis of plasmids from single colonies before screening. Table 4a ). DNA libraries were constructed by standard overlap extension PCR (as described above) using degenerate primers (Supplementary Table 3 ). Subsequently, beneficial mutations were assembled step-wise and the improvement factor was calculated from the activity rates determined in lysate screens (Supplementary Table 4b 37 . Because hits at positions 88 and 89/90 were too close to be efficiently combined by DNA shuffling, another focused library was prepared using very limited codon sets based on hits from round 15. Position 88 was randomized with an SMT codon (Asp, Pro, His and Ala), position 89 with MRT (Asn, His, Ser and Arg), and position 90 with a mix of YAC (Tyr and His) and TYT (Phe and Ser). This library was combined in a 1:4 molar ratio with a mix of HG3.7, 5 clones from round 14, and 14 clones from round 15 and shuffled according to standard protocols 33 to yield library 16. Site-directed mutagenesis. The role of selected active site residues in HG3.17 was assessed by site-directed mutagenesis. For example, Asp 127, the intended catalytic base, was mutated to alanine and asparagine (primer sequences, Supplementary  Table 3 ), whereas Gln 50, which emerged in round 4 of the directed evolution experiment, was mutated to alanine. Full-length genes were assembled using standard library cloning primers (T7 terminator and T7 alternative, Supplementary Table 3) . Ligation into the pET-11b(1) vector and subsequent transformation were performed as described above. Screening rounds 1 to 10. Typically, 800-1,000 clones were screened per evolutionary round. HG3 gene libraries were transformed into BL21-Gold(DE3) cells and plated onto LB agar plates containing 150 mg ml 21 ampicillin. Single colonies were used to inoculate 180 ml LB medium containing 150 mg ml 21 ampicillin (LB-Amp 150 ) in a 96-well plate. After overnight incubation at 37 uC, replica plates were generated. The overnight cultures were used to inoculate 2 ml LB-Amp 150 medium in 96-deepwell plates. The E. coli variants were grown for 5 h at 37 uC before protein production was induced by addition of isopropyl-b-D-thiogalactoside (IPTG; 1 mM final concentration). The temperature was reduced to 18 uC and protein production continued for 18 h. The cells were collected by centrifugation, the supernatant was discarded, and the cell pellets were frozen at 280 uC for at least 1 h. After thawing, the cells were resuspended in 300 ml lysis buffer consisting of 50 mM sodium phosphate, pH 7.0, 100 mM NaCl and 1 mg ml 21 lysozyme. The cells were incubated for 1 h at room temperature before clearing the lysates by centrifugation. Catalytic efficiency was assayed by monitoring conversion of 5-nitrobenzisoxazole (250 mM final concentration) at 380 nm in a plate reader (ThermoFisher) at 27 uC. The most active clones were confirmed by rescreening in triplicate. The clones with the largest increase in activity relative to the preceding round, typically corresponding to about 1% of the screened population, were picked from the replica plate for plasmid isolation, sequencing and further diversification. Screening rounds 11 to 17. For rounds 11 to 17, HG3 libraries were cloned via NcoI and XhoI sites into expression vector pMG209, derived from pET-22b (Novagen) 38 .
At the 59 end of the insert, pMG209 encodes the periplasmic export sequence pelB in frame with the protein. Protein was expressed for 16-20 h at 18 uC and cells were stored at 4 uC until the catalytic assay was performed. Directly before the assay, cells were resuspended with a Liquidator 96 (Rainin). If necessary, cells were diluted in reaction buffer (50 mM sodium phosphate, pH 7, 100 mM NaCl) up to 100-fold. The assay reaction was performed with 20 ml of diluted or undiluted cell suspension in a total volume of 200 ml reaction buffer containing 125-250 mM 5-nitrobenzisoxazole and 1% MeCN in Nunclon coated flat-bottom plates (Nunc). Reaction progress was monitored in a plate reader (Molecular Devices) at 380 nm wavelength and 27uC. The most active clones were picked directly from the protein production plate for further characterization. Protein production and purification. Selected variant(s) along the evolutionary trajectory were produced and purified for biochemical characterization. BL21-Gold (DE3) cells were transformed with the pET-11b(1) expression vector (Novagen) containing the gene of interest. To ensure monoclonality, single-colony streakouts were prepared to inoculate an overnight culture in LB-Amp
150
. A 2-l Erlenmeyer flask containing 500 ml LB-Amp 150 was inoculated with 1 ml of the overnight culture and incubated until an attenuance (D 600 nm ) of 0.5-1 at 37 uC. The temperature was then reduced to 18 uC, and protein production induced with 250 mM IPTG. After 18-24 h, the cells were collected and cell pellets were frozen at 220 uC. After thawing, pellets were resuspended in sonication buffer (50 mM Tris-HCl, pH 7.4, 500 mM NaCl) and 100 ml of a protease inhibitor cocktail (Sigma, P8849) added. Cells were lysed by addition of 0.5 mg ml 21 lysozyme and subsequent sonication. Cell debris was removed by centrifugation, and the soluble fraction was applied to a Ni-NTA resin (Qiagen) pre-equilibrated with sonication buffer. The samples were washed with the same buffer containing 20 mM imidazole before elution with 300 mM imidazole. The protein samples were washed into fast protein liquid chromatography (FPLC) buffer (20 mM sodium phosphate, pH 6, 20 mM NaCl) in an Amicon Ultra-15 centrifugal filter (10 kDa cut-off, Millipore) and then further purified by cation exchange chromatography (MonoS column, GE Healthcare) in the same buffer, eluting with a salt gradient (20-1,000 mM NaCl). The protein of interest typically eluted at a conductivity of 24 mS cm 21 . If necessary, proteins were concentrated using an Amicon Ultra-4 unit (10 kDa cut-off, Millipore). Protein concentrations were determined by measuring the absorbance at 280 nm using a calculated extinction coefficient (http://expasy.org/tools/ protparam.html). Protein purity was confirmed by SDS-PAGE. Pure protein was stored in FPLC buffer at 4 uC. The most active variant, HG3.17, retained full activity for several months under these conditions. Circular dichroism spectroscopy. The far-ultraviolet spectrum of protein samples (5 mM) was measured in 50 mM sodium phosphate buffer, pH 7.0, and 100 mM NaCl at 20 uC using an Aviv 202 spectropolarimeter (Aviv Associates). Thermal denaturation of the protein (5 mM) was monitored at 222 nm. Mass spectrometry. For mass determination, protein samples were desalted on Illustra Nap-5TM columns (GE Healthcare) and measured in 0.1% acetic acid by RESEARCH LETTER electrospray ionization-mass spectrometry (ESI-MS) on a Daltonics maXis ESI-Q-TOF mass spectrometer (Bruker). Mass spectra were deconvoluted using MaxEnt1 software. All masses corresponded to the expected sequence lacking the N-terminal methionine. Substrate synthesis. 5-Nitrobenzisoxazole, 5-bromobenzisoxazole and 5-nitro-7-methoxybenzisoxazole were synthesized from the respective salicylaldehyde by first forming the oxime and then cyclizing with Ph 3 P and DDQ
39
. 5-Chlorobenzisoxazole, 5-cyanobenzisoxazole and 6-nitrobenzisoxazole were synthesized as previously described 9 . Ultraviolet/visible spectroscopic assay. Reactions were initiated by adding enzyme (10 nM-10 mM) to the benzisoxazole substrate (50 mM-2 mM final concentration) in 50 mM sodium phosphate buffer, 100 mM NaCl, containing 10% methanol, pH 7.0. The pH of the buffer was measured after addition of methanol using a SenTix 81 pH electrode (Gerber Instruments). Product formation was monitored at the appropriate wavelength 40 at 338 nm for 5-bromobenzisoxazole, were determined in alkaline aqueous solution. Leaving group pK a values were determined spectrophotometrically. For reactions at high substrate concentration (for example, Fig. 2d ), product formation was monitored at 455 nm. After completion of the reaction, the sample was diluted 100-fold and product concentration determined from the absorbance at 380 nm as previously described 40 . Substrate solubility. K m values of all HG3 variants were high compared to the solubility limit of the substrate. Solubility of 5-nitrobenzisoxazole under the assay conditions was quantified by diluting a 50 mM stock solution in methanol tenfold with assay buffer. The insoluble material was removed by centrifugation and the clear supernatant diluted into 100 mM NaOH solution. After complete conversion to 2-hydroxy-5-nitrobenzonitrile, the product was quantified spectrometrically. The solubility limit of 5-nitrobenzisoxazole under these conditions was determined to be 2.2 mM. For every kinetic assay, the background rate was plotted against the substrate concentration and a linear correlation served as evidence for the absence of non-ideal effects near the solubility limit. K i determination. HG3 variants (25 nM-1 mM final concentration, depending on their respective activity) were pre-incubated with varying concentrations of 6-nitrobenzotriazole (3) (0.001-1,000 mM final concentrations) in 50 mM Bis-Tris propane buffer, pH 6, containing 100 mM NaCl, 10% methanol and 1% dimethylsulphoxide (DMSO), and reactions were initiated by addition of 5-nitrobenzisoxazole (100 mM final concentration). Product formation was monitored as described previously. Half-maximum inhibitory concentration (IC 50 ) values were determined by curve fitting (Hill-slope model with the rate at infinite inhibitor concentration set to 0) and assumed to be equal to the K i value at [S] = K m according to the ChengPrusoff equation 41 :
pH-rate profile. The pH dependence of k cat /K m was determined by measuring initial rates at 100 mM 5-nitrobenzisoxazole in different buffers. Acetate buffer was used from pH 4-5.5 and Bis-Tris propane buffer from pH 6-9.5, both containing 100 mM NaCl and 10% methanol. Enzyme was preincubated in the assay buffer for at least 5 min at 27 uC before initiation of the reaction by substrate addition. The rate of the uncatalysed reaction was measured with an identical sample without enzyme and subtracted. The apparent extinction coefficient for 5-nitro-2-hydroxybenzonitrile at 380 nm was corrected for the ionization state of the product using the formula e 380 nm 5 e max /(1 1 10 pKa 2 pH ); the product has a pK a of 3.98 and an e max of 15,800 M 21 cm 21 when fully deprotonated. Crystallization of HG3.17 complexed with a transition state analogue. Because crystallization trials with HG3.17 only yielded fine needles, a variant of the protein was chosen for detailed structural study in which two surface mutations (Asn47Glu and Asp300Asn) potentially involved in crystal contacts were reverted. This variant (100 mM) was incubated with 1 mM 6-nitrobenzotriazole (3) in 5 mM monobasic sodium phosphate, 100 mM sodium chloride, pH 7.0, containing 1% DMSO. The complex was crystallized by vapour diffusion in sitting drops comprising 200 nl of the enzyme-3 solution, 200 nl mother liquor (1.1 M ammonium sulphate, 100 mM sodium acetate, pH 5.9), and 50 nl diluted seed stock. HG3.7, a variant from the seventh round of evolution that readily crystallized, was used for cross-seeding. The seeds were generated with Seed Beads (Hampton Research) using pooled single crystals of HG3.7 grown in 1-2.5 M ammonium sulphate, 100 mM sodium acetate, pH 5-6.5. A 2.0 M ammonium sulphate solution was used as a crystalstabilizing agent to collect the crystals and for dilution of seed stocks. Initial seed stocks were diluted 1:1,000 to ensure that the crystals of the HG3.17 variant were not significantly contaminated with HG3.7. Under optimized sitting drop vapour diffusion conditions, one or two crystals were obtained per drop. Crystals were cryoprotected in mother liquor complemented with 20% (v/v) glycerol and flash frozen in liquid nitrogen. Crystallographic methods. Crystallographic data were collected at 100 K using l 5 1.00 Å at the Swiss Light Source (SLS) PXI-X06SA beamline (Paul Scherrer Institute, Villigen, Switzerland). The diffraction data were indexed and integrated with XDS 42 . Crystals belong to space group P2 1 2 1 2 1 (a 5 76.08 Å , b 5 77.95 Å , c 5 98.28 Å , a 5 b 5 c 5 90u). The structure was solved by molecular replacement using PHASER 43 starting with the deposited model of HG2 (PDB accession code 3NYD) 3 . HG2, which was the direct precursor of HG3, has a serine residue at position 265 rather than a threonine as in HG3. The structure was refined in PHENIX 44 with manual corrections made in COOT 45 . The asymmetric unit contains two independent chains of HG3.17 denoted 'A' and 'B'. The maximum-likelihood target function was used with optimized stereochemical and atomic-displacement parameter restraints for most of the refinement. In the final stage, the ligand as well as the catalytic residues Asp 127 and Gln 50 for the A-chain were refined unrestrained, using the least squares target function. The electron density reveals single conformations for most residues of the A-chain and two alternative conformations for the entire B-chain. The alternative B-chain conformations are modelled as a 1.2 6 0.6 Å rigid-body shift. To rule out the possibility that this observation was caused by improper space group assignment, the structure was refined in space group P1, all crystallographic subgroups of P2 1 2 1 2 1 , as well as in space group P2 1 . Because the alternative conformations were seen in all cases, we concluded that both B-chain conformations are not systematically distributed throughout the asymmetric units of lower symmetry space groups, as previously observed 3 for the B-chain of HG2. Although crystals diffracted to higher resolution, data were cut off at 1.09 Å because completeness dropped significantly below 50% in higher resolution shells. The backbone dihedral angles were distributed within the most favoured (98.7%) and additionally allowed (1.3%) regions of the Ramachandran map. Details of the refinement statistics are summarized in Supplementary Table 2 . Structural analysis. The length and width of the substrate entry tunnel were measured with the PyMOL plugin Caver 3.0 (ref. 46) . The hydrogen-bonding interaction between Asp 127 and the transition state analogue was analysed by comparison with the optimal angles calculated for hydrogen-bonding interactions between acetamide dimers 47 .
